Product Information
DESMOPRESSIN ACETATE 0.2 MG TB is a generic product labeled by KVK-Tech Inc., priced at $0.3726 per EA under NDC 10702017001. Its NADAC has been published 329 times since Sep 11, 2019.
FDA first approved this application on Jan 28, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.2 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702017001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESMOPRESSIN ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA210371FDA Approved
1/28/2019
TE Code
AB
On Market Since
1/28/2019
Pharmacological Classes
Price Statistics
The NADAC for DESMOPRESSIN ACETATE 0.2 MG TB has been published 329 times since Sep 11, 2019, and over the history we have for it it has declined 39.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3726 per EA |
|---|---|
| All-time high | $0.6458 (Jan 15, 2020) |
| All-time low | $0.3345 (Apr 19, 2023) |
| 52-week high | $0.3806 |
| 52-week low | $0.3569 |
| Median price | $0.4280 |
| Average price | $0.4495 |
| Largest weekly change | +24.0% (May 17, 2023) |
| Weeks tracked | 329 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desmopressin Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor VIII Activator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESMOPRESSIN ACETATE 0.2 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for DESMOPRESSIN ACETATE 0.2 MG TB, manufactured by KVK-Tech Inc., is $0.3726 per EA (NDC 10702017001), effective Sep 30, 2026.
How has the price of DESMOPRESSIN ACETATE 0.2 MG TB changed over time?
Over the history we have for it, the NADAC for DESMOPRESSIN ACETATE 0.2 MG TB has declined 39.0%. It has been tracked across 329 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for DESMOPRESSIN ACETATE 0.2 MG TB?
Since Sep 11, 2019, the NADAC for DESMOPRESSIN ACETATE 0.2 MG TB has ranged from a low of $0.3345 (Apr 19, 2023) to a high of $0.6458 (Jan 15, 2020), with a median of $0.4280 per EA.
Are there cheaper alternatives to DESMOPRESSIN ACETATE 0.2 MG TB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESMOPRESSIN ACETATE 0.2 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures DESMOPRESSIN ACETATE 0.2 MG TB?
DESMOPRESSIN ACETATE 0.2 MG TB (NDC 10702017001) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.